The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenvatinib plus everolimus (LenEve) in patients with pre-treated advanced renal cell carcinoma (mRCC): Real world evidence (Relevance).
 
Philipp Ivanyi
Stock and Other Ownership Interests - BB Biotech Ventures
Honoraria - AIMM Therapeutics; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD Oncology; Roche Pharma AG
Consulting or Advisory Role - Bayer/Vital; Bristol-Myers Squibb; Eisai; Ipsen; Merck Serono; MSD; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
Other Relationship - Merck Serono; Pfizer
 
Hendik Eggers
Honoraria - Eisai Germany
 
Ramona Stelmach
Honoraria - Pfizer
Travel, Accommodations, Expenses - Astellas Amgen BioPharama
 
Martin Boegemann
Employment - Janssen; Janssen
Honoraria - Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; ipsen; Janssen-Cilag; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - IPSEN (Inst); Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Bayer; BMS GmbH & Co. KG; Janssen-Cilag
 
Arne Strauß
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD Oncology; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck Serono; MSD; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen-Cilag (Inst); MSD Oncology (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Ipsen
 
Christian Thomas
Stock and Other Ownership Interests - Orion Biotechnology
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - BMSi; Janssen Oncology; MSD Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Johannes Landmesser
No Relationships to Disclose
 
Mario W Kramer
No Relationships to Disclose
 
Stefanie Zschaebitz
Honoraria - Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis; Pfizer (Inst)
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Gilead Sciences; Ipsen; Merck; MSD Oncology; Pfizer (Inst); Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; BMS GmbH & Co. KG; Ipsen; Janssen Oncology; Merck; Pfizer